A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor

Summary

This multi-center, randomized, double-blinded, placebo-controlled, dose-range-finding clinical trial (with an optional Extension comprised of an Extension Double-blind (DB) Lead in Period followed by an Extension Open-label (OL) Period) that will assess the efficacy, safety, and tolerability of PRAX 944 in participants aged 18 years or older who have a diagnosis of Essential Tremor (ET) and have had symptoms for at least 3 years.

Timeline

Start

2021-10-14

Primary completion

2023-02-09

Completion

2024-02-29

Drugs

Indications